- Research works
- 113 ▲ 97% vs 2018-21
- Citations
- 2.7k 23.8 per fractional work
- Top-10% rate
- 11.6% all institutions 10.0%
- Open access
- 26% world 40%
- International
- 39% world 18%
Not ranked overall: Octapharma (Austria) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Octapharma (Austria) work in?
In all years, 57% of research at Octapharma (Austria) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (18%), Chemistry (7%). It does 2.3× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 16 fields, with their numbers
- Health Sciences6557.2%
- Medicine6255.2%
- Health Professions10.8%
- Nursing10.6%
- Veterinary10.5%
- Life Sciences2824.7%
- Physical Sciences1513.7%
- Chemistry87.4%
- Engineering43.8%
- Environmental Science11.2%
- Materials Science11.2%
- Physics and Astronomy00.1%
- Computer Science00.1%
- Social Sciences54.5%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 13.6×. Every wedge is a field page.
All 11 fields, with their numbers
- Veterinary13.55×0 works
- Chemistry4.11×1 works
- Medicine3.20×11 works
- Business, Management and Accounting2.67×2 works
- Pharmacology, Toxicology and Pharmaceutics2.61×0 works
- Nursing2.16×0 works
- Immunology and Microbiology1.92×0 works
- Biochemistry, Genetics and Molecular Biology1.87×2 works
- Environmental Science0.93×1 works
- Engineering0.20×0 works
- Health Professions0.08×0 works
Who are the top researchers at Octapharma (Austria)?
Ranked on the quality score, Martina Jansen, Andrea Buchacher and Elisabeth Clodi lead among researchers whose main affiliation is Octapharma (Austria).
- 1
Martina Jansen
Austria · #1,175,260 worldwide 587 citations · 35 works
- 2
Andrea Buchacher
Austria · #1,408,000 worldwide 3.7k citations · 51 works
- 3
Elisabeth Clodi
Austria · #1,434,621 worldwide 326 citations · 16 works
- 4
Dj. Josić
Austria · #3,515,695 worldwide 618 citations · 24 works
- 5
Stefan Wietek
Austria · #3,704,652 worldwide 286 citations · 22 works
- 6
Andrea Heger
Austria · #4,319,642 worldwide 520 citations · 34 works
- 7
Andrea Neisser‐Svae
Austria · #4,357,170 worldwide 268 citations · 16 works
- 8
Katharina Pock
Austria · #4,470,044 worldwide 495 citations · 32 works
- 9
Tor‐Einar Svae
Austria · #4,599,507 worldwide 344 citations · 23 works
- 10
Marnix R. Jansen
Austria · #4,723,108 worldwide 230 citations · 36 works
Which keywords describe research at Octapharma (Austria)?
By fractional works in all years, weighted toward what it does more of than the world: Hemostasis, Monoclonal Antibodies, Anemia, Blood Transfusion, Therapeutic Antibodies, Inflammation, Prophylaxis and Gene Therapy.
- Resuscitation
- Gas Chromatography
- Sepsis
- Liquid Chromatography
- Protease-Activated Receptors
- Blood Groups
- Glycosylation
- Supply Chain Management
- Risk Factors
- Cardiac Surgery
- Immune Thrombocytopenic Purpura
- Stability
- Immunogenicity
- Thrombosis
- Recombinant Factor VIIa
- Factor VIII
- Gene Therapy
- Therapeutic Antibodies
- Monoclonal Antibodies
- Hemostasis
- Inflammation
- Anemia
- Blood Transfusion
- Prophylaxis
- Protein Aggregation
- Hemophilia
- Hemorrhage
- Biopharmaceuticals
- Recombinant Proteins
- Critical Care
- Platelets
- Tranexamic Acid
- Blood Donation
- Antithrombotic Therapy
- Alloimmunization
- Pregnancy
- Thrombin
- Mass Spectrometry
- Chiral Separation
- Coagulopathy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation14▲ 5.1×14 topics
- Hemostasis14▲ 80×3 topics
- Anemia12▲ 90×3 topics
- Monoclonal Antibodies12▲ 73×3 topics
- Blood Transfusion12▲ 192×2 topics
- Therapeutic Antibodies12▲ 79×2 topics
- Prophylaxis10▲ 64×2 topics
- Gene Therapy10▲ 34×4 topics
- Protein Aggregation10▲ 111×2 topics
- Factor VIII10▲ 498×1 topic
- Hemophilia10▲ 498×1 topic
- Recombinant Factor VIIa10▲ 205×2 topics
- Hemorrhage10▲ 117×2 topics
- Thrombosis9▲ 37×5 topics
- Biopharmaceuticals9▲ 113×2 topics
- Immunogenicity9▲ 151×2 topics
- Recombinant Proteins8▲ 141×1 topic
- Stability8▲ 39×1 topic
- Critical Care7▲ 28×3 topics
- Immune Thrombocytopenic Purpura7▲ 159×1 topic
- Platelets7▲ 98×1 topic
- Cardiac Surgery7▲ 75×1 topic
- Tranexamic Acid7▲ 281×1 topic
- Risk Factors6▲ 4.6×2 topics
- Blood Donation5▲ 300×1 topic
- Supply Chain Management5▲ 8.7×1 topic
- Antithrombotic Therapy5▲ 39×2 topics
- Glycosylation4▲ 18×3 topics
- Alloimmunization4▲ 101×1 topic
- Blood Groups4▲ 101×1 topic
- Pregnancy4▲ 17×2 topics
- Protease-Activated Receptors4▲ 101×1 topic
- Thrombin4▲ 101×1 topic
- Liquid Chromatography4▲ 21×2 topics
- Mass Spectrometry4▲ 15×4 topics
- Sepsis3▲ 18×2 topics
- Chiral Separation3▲ 23×1 topic
- Gas Chromatography3▲ 23×1 topic
- Coagulopathy3▲ 33×2 topics
- Resuscitation3▲ 21×2 topics
Which research topics does Octapharma (Austria) publish most on?
By volume in 2022-now: Blood transfusion and management, Hemophilia Treatment and Research, Blood donation and transfusion practices and Trauma, Hemostasis, Coagulopathy, Resuscitation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Blood transfusion and management Biochemistry 2 works
- 2 Hemophilia Treatment and Research Hematology 2 works
- 3 Blood donation and transfusion practices Management of Technology and Innovation 2 works
- 4 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 1 works
- 5 Protein purification and stability Molecular Biology 1 works
- 6 Platelet Disorders and Treatments Hematology 1 works
- 7 Inflammatory Myopathies and Dermatomyositis Epidemiology 1 works
- 8 Analytical Chemistry and Chromatography Spectroscopy 0 works
- 9 Organ Donation and Transplantation Public Health, Environmental and Occupational Health 0 works
- 10 Reproductive biology and impacts on aquatic species Physiology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Octapharma (Austria)'s research output changed?
Output in 2022-2025 was 97% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Octapharma (Austria) as a percentage of every work published that year, 0.000039% in 2024.
Fractional works of Octapharma (Austria) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Vienna
- University of Vienna
- TU Wien
- Medical University of Vienna
- Austrian Academy of Sciences
- BOKU University
- Vienna University of Economics and Business
- University of Veterinary Medicine Vienna
- Austrian Institute of Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Octapharma (Austria). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.